| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2007 | CN1325507C 17alpha-alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations |
| 07/11/2007 | CN1325502C Purple bergenia element pentaacetylate and its uses |
| 07/11/2007 | CN1325501C Heterocyclic compounds |
| 07/11/2007 | CN1325500C Furyl compounds |
| 07/11/2007 | CN1325499C Thienyl compounds |
| 07/11/2007 | CN1325498C Novel crystalline compound |
| 07/11/2007 | CN1325497C Pharmaceutically active isoindoline derivs. |
| 07/11/2007 | CN1325494C 3-substituted nalidixic acid analog compound and its preparation method and uses in pharmacy |
| 07/11/2007 | CN1325493C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
| 07/11/2007 | CN1325491C Novel crystals |
| 07/11/2007 | CN1325489C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 07/11/2007 | CN1325488C Heterocyclic derivatives |
| 07/11/2007 | CN1325487C Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents |
| 07/11/2007 | CN1325482C Biscyanophenylmethyl-triazole for use in prevention of breast cancer |
| 07/11/2007 | CN1325480C Novel phenylalanine derivatives |
| 07/11/2007 | CN1325479C Pyrimidine compounds |
| 07/11/2007 | CN1325476C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents |
| 07/11/2007 | CN1325475C Quinoline derivatives and their use as mycobacterial inhibitors |
| 07/11/2007 | CN1325473C Novel azasugar derivative and drug containing the same as the active ingredient |
| 07/11/2007 | CN1325465C High purity (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof, preparation and the me |
| 07/11/2007 | CN1325462C Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising the |
| 07/11/2007 | CN1325454C Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 07/11/2007 | CN1325128C Microencapsulated fragrances and methods of coating microcapsules |
| 07/11/2007 | CN1325117C 联合疫苗组合物 Combined vaccine composition |
| 07/11/2007 | CN1325108C Lesser galangal extract and its use |
| 07/11/2007 | CN1325089C Chinese patent medicine on health food composition and its use |
| 07/11/2007 | CN1325071C Antiphlogistic medicine |
| 07/11/2007 | CN1325065C Composition for improving intestine and gastric action |
| 07/11/2007 | CN1325063C L-amino acid water-soluble pearl powder and its preparing method |
| 07/11/2007 | CN1325062C Method for obtaining binded estrogen mixture from pregnant horse urine, and its uses of big pore adsorption resin in the method |
| 07/11/2007 | CN1325060C Medicated cream and its prepn process |
| 07/11/2007 | CN1325057C Use of corrinoids in the treatment of skin diseases |
| 07/11/2007 | CN1325056C Chloasma amelioration composition and dullness amelioration composition |
| 07/11/2007 | CN1325055C Application of stevioside R1 and its derivative as medicine for preventing and treating neurodegeneration disease |
| 07/11/2007 | CN1325054C Cyclic dextrin inclusion compound of mintpress hydrochloride and its preparing method |
| 07/11/2007 | CN1325053C Controlled-release drug composition |
| 07/11/2007 | CN1325052C Benzothiazole derivatives |
| 07/11/2007 | CN1325051C Compound medicine of ozagrel and its salt and troxerutin |
| 07/11/2007 | CN1325050C Pharmaceutical composition comprising a lipase inhibitor and glucomannan |
| 07/11/2007 | CN1325049C Composition containing epigallocatechin gallate |
| 07/11/2007 | CN1325048C Application of wogonin for preparing medicine to treat or prevent hepatitis B |
| 07/11/2007 | CN1325047C Dementholized mint oil dripping pill |
| 07/11/2007 | CN1324965C Disinfecting composition based on H2O2 acids and metal ions |
| 07/10/2007 | USRE39723 Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 07/10/2007 | US7241923 Phenylalkyloxy-phenyl derivatives |
| 07/10/2007 | US7241921 hydroxamic acid and N-formyl hydroxylamine compounds which inhibit the activity of the bacterial enzyme known as peptide deformylase |
| 07/10/2007 | US7241917 for treatment of viral infection, tumor, AIDS, fever, ache, and constipation, improvement of immunity, kidney function, neural regulation and physical recovery |
| 07/10/2007 | US7241913 Ruthenium compounds |
| 07/10/2007 | US7241909 useful in treating biological disorders mediated by vitamin D receptors and/or in treating disorders where a rise in serum calcium is undesirable |
| 07/10/2007 | US7241907 Acetone solvate of dimethoxy docetaxel and its process of preparation |
| 07/10/2007 | US7241900 Synthesis of indole thiazole compounds as ligands for the Ah receptor |
| 07/10/2007 | US7241899 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 07/10/2007 | US7241894 Antitumor agents |
| 07/10/2007 | US7241892 Hemisynthetic method and new compounds |
| 07/10/2007 | US7241890 Heat shock protein 90 inhibitors; breast cancer, melanomas; inflammation, infectious diseases, autoimmune disorders, ischemia |
| 07/10/2007 | US7241889 2-Amino-5-formyl-substituted, e.g., 2-[p-(cyclopropylaminocarbonyl)phenyl]-5-formyl-8-isopentyl--7-methyl-5,6,7,8-tetrahydropteridine; antiproliferative agents |
| 07/10/2007 | US7241888 Process for preparing 10α-[4′-(S,S-dioxothiomorpholin-1′-yl)]-10-deoxo-10-dihydroartemisinin |
| 07/10/2007 | US7241887 3-azabicyclo[3.2.1]octane derivatives |
| 07/10/2007 | US7241886 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b, f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5h-dibenz/b, f/azepine-5-carboxamide |
| 07/10/2007 | US7241875 alkyl and/or alkenyl oligoglycoside is reacted with a omega -halocarboxylic or a salt or ester thereof in the presence of alkali |
| 07/10/2007 | US7241812 Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity |
| 07/10/2007 | US7241811 Amide compounds for the potentiation of cholinergic activity |
| 07/10/2007 | US7241810 For therapy of inflammatory, allergic and respiratory diseases |
| 07/10/2007 | US7241809 Administering to a subject in need thereof an effective amount of 1,4-dihydroxy-2-naphthoic acid or a salt thereof for therapy of an inflammatory bowel disease |
| 07/10/2007 | US7241808 Composition for treatment of skin and method for stabilizing the composition |
| 07/10/2007 | US7241807 For therapy and prophylaxis of diseases or disorders such as migraine headache pain and post-chemotherapy or post-operative surgery nausea and vomiting |
| 07/10/2007 | US7241805 Modified release formulations of a bupropion salt |
| 07/10/2007 | US7241804 Compositions and methods for modulating apoptosis in cells over-expressing Bcl-2 family member proteins |
| 07/10/2007 | US7241803 Compounds for inhibition of HIV infection by blocking HIV entry |
| 07/10/2007 | US7241802 Substituted cyclohexylcarboxylic acid amide compounds |
| 07/10/2007 | US7241801 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 07/10/2007 | US7241800 Anhydrous amorphous form of fluvastatin sodium |
| 07/10/2007 | US7241799 Analgesics, vision defects, antiepileptic agents, central nervous system disorders, antiinflammatory agents |
| 07/10/2007 | US7241798 For therapy of sleep disorders, autism, pervasive development disorder, rheumatoid arthritis, emesis, major depressive disorders, osteoarthritis, fibromyalgia, human immunodeficiency virus (HIV) infections, dissociative disorders, anorexia, bulimia, ulcerative colitis, Crohn's disease |
| 07/10/2007 | US7241797 Controlling serotonin concentration |
| 07/10/2007 | US7241796 Peptidomimetic compounds |
| 07/10/2007 | US7241795 2,5-bis ((alkyl (or aryl) imino) aminophenyl) furans, thiophenes or pyrroles; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp., Pneumocystis carinii, Toxoplasma gondii, Fusarium solani, and Cryptococcus neoformans |
| 07/10/2007 | US7241794 Nonnucleoside reverse transcriptase inhibitors |
| 07/10/2007 | US7241793 For therapy of cardiovascular diseases |
| 07/10/2007 | US7241792 For therapy of dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like |
| 07/10/2007 | US7241791 Substituted 4-(indazol-3-yl)phenols |
| 07/10/2007 | US7241790 For wound healing in a warm blooded vertebrate |
| 07/10/2007 | US7241789 Substituted indoles and their use as integrin antagonists |
| 07/10/2007 | US7241788 Cannabinoid receptor ligands and uses thereof |
| 07/10/2007 | US7241787 Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments |
| 07/10/2007 | US7241786 Compounds inhibit A beta -peptide production; may be used for treatment of Alzheimer's disease and other neurological disorders in mammals, including humans |
| 07/10/2007 | US7241785 Five-membered heterocyclic alkanoic acid derivative |
| 07/10/2007 | US7241784 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 07/10/2007 | US7241783 Using a thiosemicarbazone |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241781 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 07/10/2007 | US7241780 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 07/10/2007 | US7241779 Fused pyrrolocarbazoles |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241776 Amidomethyl-substituted, e.g., N-2-(4-chlorophenyl)-N-(1-{[N-cyano-2-(2-methylphenyl) ethanimidoyl]amino}-2,2-dimethylpropyl)acetamide; useful for treating pain, inflammation and neurodegeneration states |
| 07/10/2007 | US7241775 Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines |
| 07/10/2007 | US7241774 Amines such as 6,7-bis-hydroxy-1-biphenyl-4-ylmethyl-1,2,3,4-tetrahydro-isoquinoline, used as preferential anticarcinogenic agents |
| 07/10/2007 | US7241773 E.g., 3-(3-Phenoxyphenoxy)quinuclidine and 2-(1-aza-bicyclo[2.2.2]oct-3-yloxy)-6H, 12H-5, 11-methano-dibenzo[b,f][1,5]diazocine; treating conditions or disorders prevented by or ameliorated by nicotinic acetylcholine receptors ligands such as Alzheimer's and schizophrenia |
| 07/10/2007 | US7241772 3-[3-(Pyrrolylphenoxy-2-hydroxypropyl)aminoalkyl]imidazo[1,5-a]pyridine derivatives, especially HCl salts; treating obesity |